DD
Daniel Patrick O'Day (Chairman & CEO) filed 15 Form 4 reports in the trailing twelve months (0 purchases, 15 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $19.7M of GILD (112,429 sh across 2 lots, as filed), executed Nov 4. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
15
0 buys · 15 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$76.2M
shares × price, as filed
Last traded
Nov 5
Filed Nov 6
Median ADV $1.0B across their filed names
Open performance→Volume by month
Buys $0
Sells $82.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
15 filings
Sector per market data · by filing · past 12 months
Most traded names
GILDRecent filings
GILDSALE
Gilead Sciences, Inc.
View filing →
$1.4M10,000 sh × $136.82
Exec Mar 27
Filed Mar 30 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.4M
9,900 sh across 2 lots
Exec Feb 27
Filed Mar 2 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $17.3M
115,640 sh × $150.00
Exec Feb 5
Filed Feb 6 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.4M
10,000 sh across 2 lots
Exec Jan 28
Filed Jan 29 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $15.6M
115,640 sh × $135.00
Exec Jan 23
Filed Jan 26 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.2M
10,000 sh × $124.83
Exec Dec 29 2025
Filed Dec 30 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.3M
10,000 sh across 2 lots
Exec Nov 28 2025
Filed Dec 1 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.2M
10,000 sh across 2 lots
Exec Oct 28 2025
Filed Oct 29 2025 · 5:30 PM ET More filings →